HTATIP2 and hepatocellular carcinoma: Our previous studies have also demonstrated that sorafenib promotes invasiveness and metastasis of HCC through downregulation of HIV-1 Tat interactive protein 2 (HTATIP2) using animal tumor models[10, 11]; nonetheless, the clinical significance of the latter finding has not been fully elucidated.